Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in France / NCT06724718
Recruiting Not applicable

Diagnosis of Atrial Fibrillation in Postoperative Thoracic Surgery Using a Smartwatch

NCT06724718 · tracked via the Priya Life Science France tracker
Sponsor
Centre Hospitalier Universitaire, Amiens
Phase
Not applicable
Started
2025-06-01
Last updated
2025-06-12

Condition(s) studied

Postoperative Atrial FibrillationThoracic SurgerySmartwatchesRhythm MonitoringCardiovascular PrognosisAsymptomatic Atrial FibrillationRandomized Trial

Investigational drug(s) / intervention(s)

smartwatchECG

smartwatch: Patients in the smartwatch group will undergo rhythm monitoring with a smartwatch

ECG: Detected POAF episodes will be confirmed via a 12-lead ECG

Study summary

Postoperative atrial fibrillation (POAF) occurs in approximately 20% of patients following thoracic surgery. Early diagnosis is essential to prevent complications such as heart failure, stroke, myocardial infarction, and increased mortality. Smartwatches equipped with single-lead ECG capabilities and algorithms to detect asymptomatic atrial fibrillation (AF) offer a potential solution. This study aims to evaluate the effectiveness of smartwatches in detecting POAF compared to standard care.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adults (\>18 years old). * Patients undergoing major thoracic surgery with one-lung ventilation within the past 48 hours. * Scheduled pneumonectomy or lobectomy. * Admission to a conventional surgical unit postoperatively. * Ability to perform single-lead ECG using a smartwatch. * Coverage under a social security system. * Signed informed consent Exclusion Criteria: * History of atrial fibrillation. * Requirement for telemetry for AV block or tachyarrhythmias (\>140 bpm). * Dependency on a pacemaker. * Participation in another interventional clinical trial affecting POAF incidence. * Mediastinal, pleural, or chest wall surgery. * Reoperations or surgeries performed more than 48 hours prior. * Pregnant women. * Patients under guardians or similar legal protection.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Centre hospitalier Amiens Amiens France Recruiting

More Centre Hospitalier Universitaire, Amiens trials in France

Optimizing Sleep Maternal-Offspring Bonding and Sleep in the Maternity Ward Recruiting
Predictive Value of Systolic Rise Time of the Plantar Arch on the Risk of Major Adverse Limb Events (MALE) and Major Adverse Cardiovascular Events (MACE) in Peripheral Artery Disease (PAD) at Critical Ischaemia Stage Recruiting
Lung Ultrasound-guided Hemodynamic Optimization Recruiting
Breastfeeding Failure: Influence of Smartphone Use and Distraction Factors Recruiting
Screening for Cancers in the Oral CAvity Recruiting

Other trials for the same condition

Prognosis of Veno-Venous Extracorporeal Membrane Oxygenation in Emergency Thoracic Surgery Recruiting
Multiparametric MRI Assessment of Atrial Heart Disease as a Predictor of Atrial Fibrillation After Myocardial Revascularization Surgery Starting soon
Perioperative Inhaled Therapy in Carcinological Thoracic Surgery in Patients at High Risk of Postoperative Pulmonary Complications Recruiting
Risk Factors of Atrial Fibrillation After Cardiac Surgery Starting soon
Cardiovascular Outcome of Cancer Patients: The "GMEDICO Cohort" Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06724718 on ClinicalTrials.gov ↗ ← All trials in France